Adam Cohen - Profile and Investment Details

Investor Profile

Adam Cohen is a Venture Capital, Investor based in New York City, New York, United States with a diverse investment portfolio that includes companies such as FineHeart, Provasculon, Laurantis Pharma, DecImmune Therapeutics, Gila Therapeutics, Herantis Pharma, Aria CV, Remedy Pharmaceuticals, Apama Medical, CroíValve, ZZ Biotech, Adient Medical, HAYA Therapeutics, Intravascular Imaging Incorporated, NIDO, G.I. Windows, NuPulseCV, 480 Biomedical, Cardero Therapeutics, Epirium Bio, Allosteros, AtaCor Medical, Alleviant Medical, CardiaLen, Aggamin Biologics, Mellitus, Basking Biosciences, InfoBionic, Vectorious Medical Technologies, Ischemia Care, Capricor Therapeutics, CellAegis Devices, Renovacor, Vascular Graft Solutions, CardiAQ Valve Technologies, Antag Therapeutics, Ventrinova, Pulmokine, BioKier, Zumbro Discovery, Viridian Therapeutics, Acesion Pharma, Aeromics, Pfizer. Over time, Adam Cohen has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Adam Cohen is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Wellness, Corporate Social Responsibility Management, Women Founded, Rare Diseases, HR Tech, Life Science, Genetic Testing, Intellectual Property, Biotechnology, Drug Development, Precision Medicine, Clinical Trials, Research, Renewable Energy, Medical, B2B, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Adam Cohen, as their portfolio suggests a familiarity and interest in this area.

Understanding Adam Cohen’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.